The Mechanism and Potential Therapeutic Effects of Cyclosporin, Cyclophilin, Probiotics and Syndecan-1 in an Animal Model of Inflammatory Bowel Disease

• Main Authors: Laura Dosh (Author), Francesca Rappa (Author), Abdo Jurjus (Author), Gaelle Karam (Author), Roaa Lezeik (Author), Jad El Masri (Author), Fabio Bucchieri (Author), Angelo Leone (Author), Rosalyn Jurjus (Author)
• Format: Book
• Published: MDPI AG, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background:</b> Inflammatory bowel diseases (IBDs) have several treatment modalities including immunoregulators, like cyclosporine A, an immunosuppressant that interacts with cytoplasmic cyclophilin A, and probiotics. <b>Aims:</b> This study explored and compared the possi...